FaceHeart
FaceHeart Corporation is a Taiwan-based AI biosensing company developing FaceHeart Vitals, an FDA-cleared video-based software that measures vital signs via 50-second facial scans. It serves healthcare providers, device manufacturers, and consumers through SDK licensing and a mobile application.
- Company typePrivate
- Founded2018
- HeadquartersHsinchu, Taiwan
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What FaceHeart does
FaceHeart Corporation is a Taiwan-based AI biosensing company founded in 2018 and headquartered in Taipei. It develops FaceHeart Vitals™, an FDA-cleared video-based software platform that measures vital signs — heart rate, respiration rate, and blood oxygen — by applying AI image recognition to a 50-second facial scan captured through a standard smartphone camera. The company holds two FDA 510(k) clearances (k223622 for Heart Rate and k243966 for Respiration Rate) and is the first video-based vital sign solution to achieve Class II Software as a Medical Device designation, providing regulatory validation that competitors in this category must replicate.
The company monetizes primarily through SDK licensing of FaceHeart Vitals™ (registered as FH Vitals SDK) to healthcare device manufacturers and health tech platforms for embedding contactless vital sign measurement into third-party products, supplemented by a consumer-facing mobile application (FaceHeart AI HealthScan) and direct enterprise deployments to hospitals such as Bangkok Hospital. It is also extending its measurement set with beta biomarkers including HbA1c, hemoglobin, and cholesterol to address chronic disease management and remote patient monitoring use cases aligned with Medicare RPM and CCM frameworks.
FaceHeart raised $200 million in Series A funding from Taiwania Capital Management Corporation in October 2022 and has received industry recognition including Forbes Asia's 100 To Watch 2025 and the 2025 MedTech Breakthrough Awards. The company operates with 11–50 employees across primary customer segments: healthcare providers and medical institutions, device manufacturers and health tech platforms, and underserved or rural populations requiring hardware-free monitoring access.
FaceHeart firmographics
Firmographics- Name
- FaceHeart
- Legal name
- FaceHeart Corporation
- Website
- https://faceheart.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- FaceHeart Corporation is a Taiwan-based AI biosensing company developing FaceHeart Vitals, an FDA-cleared video-based software that measures vital signs via 50-second facial scans. It serves healthcare providers, device manufacturers, and consumers through SDK licensing and a mobile application.
- Ownership category
- akta.pro rank
FaceHeart industry classification
Industry- Product category
- Digital Health Monitoring Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
- akta.pro secondary industries
- Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous) (HLAHACAA), Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Pulse Oximeters & Respiratory Monitors (Consumer) (CRACAQAF)
Keywords
Where FaceHeart is headquartered
LocationHeadquarters
- HQ city
- Hsinchu
- HQ country
- Taiwan
- HQ region
- Asia
Offices1 record
Markets served
FaceHeart business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- SDK Licensing: FaceHeart licenses its FDA-cleared FaceHeart Vitals SDK to device manufacturers and health tech platforms for integration into their products and services. This appears to be the primary revenue stream, enabling contactless vital signs measurement capabilities in third-party devices.
- Mobile App (AI HealthScan): Consumer-facing mobile application that provides vital signs measurement functionality. The app processes data locally on the device and only connects to FaceHeart's license server for license validation during activation, suggesting a freemium or subscription model for consumer access.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
FaceHeart product offering
Product offeringCore offering
FaceHeart develops and licenses AI-driven video-based vital sign measurement software. Its FDA-cleared FaceHeart Vitals™ (FH Vitals SDK) measures heart rate and respiration rate via a 50-second facial scan using standard smartphone cameras, enabling contactless monitoring without specialized medical hardware. The company also offers a consumer-facing FaceHeart AI HealthScan mobile app for personal vital sign measurement.
Product overview
FaceHeart offers a platform centered on its FDA-cleared FaceHeart Vitals™ (FH Vitals SDK) software, which provides contactless video-based vital sign measurement powered by AI. The core offering integrates with a wide variety of devices and services through its SDK. The product portfolio includes the FaceHeart AI HealthScan mobile application for consumer use and is expanding with beta biomarkers (HbA1c, Hemoglobin, Cholesterol). FaceHeart positions its technology as a solution that reduces reliance on specialized medical hardware by enabling vital sign monitoring through standard smartphone cameras.
Differentiator
Problem solved
Functional benefit
Brands
- FaceHeart Vitals: AI-driven and video-based vital sign solution that measures key vital signs via a 50-second facial scan. Registered as FH Vitals SDK.
Products and services
- FaceHeart Vitals™ (FH Vitals SDK) FDA-cleared AI-driven video-based vital sign measurement software that measures key vital signs (heart rate, respiration rate) via a 50-second facial scan using standard smartphone cameras. Designed for integration into third-party devices and services by healthcare device manufacturers, health tech platforms, and enterprise healthcare systems.
- FaceHeart AI HealthScan App Mobile application that provides contactless vital sign measurement on personal devices (cellphone, digital tablet). Most data is stored locally on the device; the app only connects to FaceHeart's license server for license validation when activated, with no internet transmission of personal or health data. Targeted at individual consumers seeking personal health monitoring.
Quantifiable outcome
- 50-second facial scan provides vital sign measurements
- +3 more outcomes
Companies that use FaceHeart
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
FaceHeart technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
FaceHeart partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
FaceHeart competitors and assessment
Company assessmentDirect peers
- Binah.ai: Binah.ai offers video-based contactless vital sign measurement via facial scan, directly competing with FaceHeart Vitals SDK across the same OEM, telehealth, and enterprise healthcare channels.
- Nuralogix: Nuralogix's Anura platform measures blood pressure, heart rate, and stress from a 30-second selfie video, making it a direct video-based vital signs competitor targeting consumer health apps and OEMs.
- Oxehealth: Oxehealth provides contactless video-based vital sign monitoring for hospitals and mental health facilities, competing with FaceHeart's enterprise healthcare deployment motion.
- Biobeat: Biobeat offers remote patient monitoring via wearable chest patches measuring 13 vital signs including blood pressure and SpO2; a direct competitor in the RPM and chronic care management market where FaceHeart also plays.
- EarlySense: EarlySense provides contactless under-mattress vital sign monitoring for hospitals and post-acute care, competing in the contactless patient monitoring category where FaceHeart also operates.
- VitalConnect: VitalConnect provides wearable biosensor patches for continuous vital sign monitoring in hospital and remote settings, an alternative contactless/wearable approach for the same RPM customer segments.
- Care.ai: Care.ai offers AI-powered ambient patient monitoring with contactless vital sign sensing for hospital smart rooms, directly competing with FaceHeart's smart mirror and hospital deployment use cases.
Broad incumbents
- Current Health (Best Buy Health): Current Health, acquired by Best Buy Health, offers enterprise-grade RPM including continuous vital sign monitoring and chronic care management, competing with FaceHeart for hospital and RPM service contracts.
- Apple (Health): Apple's Health app and Apple Watch integrate heart rate, respiratory, and increasingly contactless health features; it is a broad incumbent whose consumer reach could subsume FaceHeart's prosumer/OEM use cases.
- Google Fitbit Health Solutions: Fitbit (Google) provides wearable vital sign monitoring and population health analytics, a broad incumbent in consumer and enterprise health monitoring that overlaps with FaceHeart's SDK distribution model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
FaceHeart social profiles
Digital presenceFaceHeart compliance and trust
Trust signalCompliance2 records
FaceHeart financial estimates
Financial estimateRevenue estimate
Valuation estimate
FaceHeart leadership team
Management profileNumber of profiles
Profiles2 records
FaceHeart funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FaceHeart M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FaceHeart
What does FaceHeart do?
FaceHeart develops and licenses AI-driven video-based vital sign measurement software. Its FDA-cleared FaceHeart Vitals™ (FH Vitals SDK) measures heart rate and respiration rate via a 50-second facial scan using standard smartphone cameras, enabling contactless monitoring without specialized medical hardware. The company also offers a consumer-facing FaceHeart AI HealthScan mobile app for personal vital sign measurement.
Is FaceHeart a public or private company?
FaceHeart is a private company. It is classified as venture growth investor backed and is currently operating.
When was FaceHeart founded?
FaceHeart was founded in 2018. It employs 11 to 50 people.
Where is FaceHeart based?
FaceHeart is headquartered in Hsinchu, Taiwan, in the Asia region.
How does FaceHeart make money?
Two revenue lines are on record. SDK Licensing is the primary driver. The others are mobile App (AI HealthScan).
Who are FaceHeart's main competitors?
Direct peers on record are Binah.ai, Nuralogix, Oxehealth, Biobeat, EarlySense, VitalConnect and Care.ai. Broad incumbents are Current Health (Best Buy Health), Apple (Health) and Google Fitbit Health Solutions.
Does FaceHeart have an API?
No public API is recorded for FaceHeart.
What industry is FaceHeart in?
FaceHeart's product category is Digital Health Monitoring Software. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous). Its NAICS code is 334510 and its SIC code is 3841.